Related Experiment Videos
Glomerular injury in malignant nephrosclerosis
Abstract:
Electron microscopic analysis of subendothelial and mesangial alterations in the glomeruli was performed in 15 cases of malignant nephrosclerosis (MNS). 8 cases showed segmental or diffuse subendothelial accumulation of proteinaceous 'fibrinoid' material associated with thickening of glomerular basement membranes. 2 of these cases also showed similar deposits in the mesangium. When severe, this mesangial insudation resulted in almost complete replacement and destruction of the mesangial matrix. Endothelial injury with alteration of glomerular microcirculation and secondary intravascular coagulation is believed to play a role in the development of the glomerular lesions in MNS.
Insights
Malignant nephrosclerosis (MNS) involves glomerular damage, with fibrinoid material accumulating under the endothelium and in the mesangium. Endothelial injury and clotting contribute to these kidney lesions.
Area of Science:
- Nephrology
- Pathology
- Electron Microscopy
Background:
- Malignant nephrosclerosis (MNS) is a severe form of hypertension-related kidney disease.
- Glomerular alterations are key pathological features of MNS.
Purpose of the Study:
- To investigate the subendothelial and mesangial changes in the glomeruli of MNS patients using electron microscopy.
Main Methods:
- Electron microscopic analysis was performed on renal biopsies from 15 MNS cases.
- Detailed examination of glomerular structures, including basement membranes and mesangial matrix.
Main Results:
- 8 out of 15 cases exhibited subendothelial fibrinoid material and glomerular basement membrane thickening.
- Two cases showed additional mesangial deposits, leading to matrix destruction in severe instances.
- Endothelial injury and intravascular coagulation were implicated in lesion development.
Conclusions:
- Subendothelial and mesangial alterations are characteristic glomerular lesions in MNS.
- Endothelial injury and secondary coagulation are crucial in the pathogenesis of MNS-related glomerular damage.